E-cadherin在甲状腺乳头状腺癌中的表达及临床意义

目的：研究Ｅ－ｃａｄｈｅｒｉｎ在甲状腺乳头状腺癌中的表达，并探讨其能否成为甲状腺乳头状腺癌独立的预后因素。方法：应用免疫组化方法，对４０例甲状腺乳头状腺癌、１０例甲状腺滤泡型腺瘤和１０例甲状腺正常组织进行了Ｅ－ｃａｄｈｅｒｉｎ表达的研究，并对可能影响甲状腺癌病人预后的有关因素进行了时序检验单因素生存分析。结果：９例（２２．５％）甲状腺乳头状腺癌Ｅ－ｃａｄｈｅｒｉｎ表达阳性，余多数呈不表达或弱阳性表

Expression of E-cadherin in papillary thyroid carcinoma and its chlinical significance

Purpose:To study the overexpressions of E cadherin and to evaluate whether it can be an independent prognostic factor for patients with papillary thyroid carcinoma. Methods:E cadherin was measured in papillary thyroid carcinomas ( n =40), normal thyroid tissues (n=10),follicular thyroid adenomas(n=10) by immunohistochemical staining. Statistical analysis was based on the Chi squard test and log rank test. Results:We found overexpression of E cadherin in 9 cases (22.5%) among 40 papillary thyroid carcinomas, and E cadherin expression was reduced in the rest of them. Only 1 case had positive expression of E cadherin in the 17 cases with lymph node metastasis. The log rank test for overall survival suggests that E cadherin was not an independent prognostic factor for papillary thyroid carcinoma. Conclusions:E cadherin expression in papillary thyroid carcinoma was reduced, and it was significantly correlated with lymph node metastasis.